Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-Naïve Adult Subjects
Status: Enrolling
Updated:  8/19/2015
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-Naïve Adult Subjects
Status: Enrolling
Updated: 8/19/2015
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-Naïve Adult Subjects
Status: Enrolling
Updated:  8/19/2015
Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)
mi
from
Burlington, VT
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-Naïve Adult Subjects
Status: Enrolling
Updated: 8/19/2015
Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)
mi
from
Burlington, VT
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-experienced Adult Subjects
Status: Enrolling
Updated:  8/19/2015
Center for Immunization Research, Johns Hopkins School of Public Health
mi
from
Baltimore, MD
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-experienced Adult Subjects
Status: Enrolling
Updated: 8/19/2015
Center for Immunization Research, Johns Hopkins School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-experienced Adult Subjects
Status: Enrolling
Updated:  8/19/2015
Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)
mi
from
Burlington, VT
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-experienced Adult Subjects
Status: Enrolling
Updated: 8/19/2015
Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)
mi
from
Burlington, VT
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-experienced Adult Subjects
Status: Enrolling
Updated:  8/19/2015
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-experienced Adult Subjects
Status: Enrolling
Updated: 8/19/2015
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Catalina Research Institute
mi
from
Chino, CA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Catalina Research Institute
mi
from
Chino, CA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Jupiter Research
mi
from
Jupiter, FL
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Jupiter Research
mi
from
Jupiter, FL
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Columbus Regional Research Institute
mi
from
Columbus, GA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Columbus Regional Research Institute
mi
from
Columbus, GA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
MedPharmics, LLC.
mi
from
Metairie, LA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
MedPharmics, LLC.
mi
from
Metairie, LA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Investigative Clinical Research
mi
from
Annapolis, MD
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Investigative Clinical Research
mi
from
Annapolis, MD
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Office of Stephen Miller, M.D.
mi
from
Las Vegas, NV
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Office of Stephen Miller, M.D.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Peters Medical Research
mi
from
HIgh Point, NC
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Peters Medical Research
mi
from
HIgh Point, NC
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers
A Phase I, Randomized, Observer-blind, Placebo Controlled Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered Intramuscularly or Intradermally by Electroporation to Healthy Adults
Status: Enrolling
Updated:  8/24/2015
Accelovance, Inc.
mi
from
San Diego, CA
Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers
A Phase I, Randomized, Observer-blind, Placebo Controlled Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered Intramuscularly or Intradermally by Electroporation to Healthy Adults
Status: Enrolling
Updated: 8/24/2015
Accelovance, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Plantar Fasciosis Treatment Using Coblation
Plantar Fasciosis Treatment Using Coblation® Prospective, Double-Blind, Randomized Controlled Study
Status: Enrolling
Updated:  8/25/2015
Weil Foot & Ankle Institute
mi
from
Des Plaines, IL
Plantar Fasciosis Treatment Using Coblation
Plantar Fasciosis Treatment Using Coblation® Prospective, Double-Blind, Randomized Controlled Study
Status: Enrolling
Updated: 8/25/2015
Weil Foot & Ankle Institute
mi
from
Des Plaines, IL
Click here to add this to my saved trials
Trial of Yellow Fever Inactivated Vaccine
Randomized, Double Blind, Controlled Phase I Trial of the Safety, Tolerability,and Immunogenicity of Graded Doses of XRX-001 Yellow Fever 17D, Inactivated Vaccine, Alum Adsorbed in Healthy Adults.
Status: Enrolling
Updated:  8/25/2015
Johnson County Clin-Trials
mi
from
Lenexa, KA
Trial of Yellow Fever Inactivated Vaccine
Randomized, Double Blind, Controlled Phase I Trial of the Safety, Tolerability,and Immunogenicity of Graded Doses of XRX-001 Yellow Fever 17D, Inactivated Vaccine, Alum Adsorbed in Healthy Adults.
Status: Enrolling
Updated: 8/25/2015
Johnson County Clin-Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
Chlorhexidine Versus Betadine in Preventing Colonization of Femoral Nerve Catheters After Total Joint Arthroplasty (TJA)
Chlorhexidine vs. Betadine in Preventing Colonization of Continuous Femoral Catheters After Total Joint Arthroplasty
Status: Enrolling
Updated:  8/26/2015
Syosset Hospital
mi
from
Syosset, NY
Chlorhexidine Versus Betadine in Preventing Colonization of Femoral Nerve Catheters After Total Joint Arthroplasty (TJA)
Chlorhexidine vs. Betadine in Preventing Colonization of Continuous Femoral Catheters After Total Joint Arthroplasty
Status: Enrolling
Updated: 8/26/2015
Syosset Hospital
mi
from
Syosset, NY
Click here to add this to my saved trials
Chlorhexidine Versus Betadine in Preventing Colonization of Femoral Nerve Catheters After Total Joint Arthroplasty (TJA)
Chlorhexidine vs. Betadine in Preventing Colonization of Continuous Femoral Catheters After Total Joint Arthroplasty
Status: Enrolling
Updated:  8/26/2015
Franklin Hospital
mi
from
Valley Stream, NY
Chlorhexidine Versus Betadine in Preventing Colonization of Femoral Nerve Catheters After Total Joint Arthroplasty (TJA)
Chlorhexidine vs. Betadine in Preventing Colonization of Continuous Femoral Catheters After Total Joint Arthroplasty
Status: Enrolling
Updated: 8/26/2015
Franklin Hospital
mi
from
Valley Stream, NY
Click here to add this to my saved trials
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
Status: Enrolling
Updated:  8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
Status: Enrolling
Updated: 8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Indiana University
mi
from
Indianapolis, IN
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Columbia University Medical Center / Center for Liver Disease and Transplantation
mi
from
New York, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Columbia University Medical Center / Center for Liver Disease and Transplantation
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Mount Sinai Hospital
mi
from
New York, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
The Digestive Disease Center at Vanderbilt
mi
from
Nashville, TN
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
The Digestive Disease Center at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Methodist Dallas Medical Center
mi
from
Dallas, TX
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Methodist Dallas Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Stanford University Medical Center, Division of Gastroenterology and Hepatology
mi
from
Palo Alto, CA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Stanford University Medical Center, Division of Gastroenterology and Hepatology
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Georgetown University Hospital
mi
from
Washington,
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Miami / Center for Liver Diseases
mi
from
Miami, FL
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Miami / Center for Liver Diseases
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Tampa General Hospital
mi
from
Tampa, FL
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Chicago Medical Center
mi
from
Chicago, IL
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Tulane University Health Science Center
mi
from
New Orleans, LA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Tulane University Health Science Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Maryland
mi
from
Baltimore, MD
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Henry Ford Hospital / Department of Gastroenterology
mi
from
Detroit, MI
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Henry Ford Hospital / Department of Gastroenterology
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Concorde Medical Group
mi
from
New York, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Concorde Medical Group
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
NYU Medical Center
mi
from
New York, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
New York Medical College / Westchester Medical Center
mi
from
Valhalla, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
New York Medical College / Westchester Medical Center
mi
from
Valhalla, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Cincinnati / Division of Digestive Diseases
mi
from
Cincinnati, OH
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Cincinnati / Division of Digestive Diseases
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Cleveland Clinic
mi
from
Cleveland, OH
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Baylor College of Medicine-St. Luke's Episcopal Hospital
mi
from
Houston, TX
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Baylor College of Medicine-St. Luke's Episcopal Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Virginia Health System
mi
from
Charlottesville, VA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials